Scarica l'app Stockscreener
16.84
0.28%
-0.115
Eton Pharmaceuticals Inc Borsa (ETON) Ultime notizie
Two Sigma Advisers LP Invests $662,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Two Sigma Investments LP Invests $1.50 Million in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why - MSN
Millennium Management LLC Acquires New Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why - sharewise
Equities Analysts Offer Predictions for ETON Q3 Earnings - Defense World
Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency - MSN
Eton Pharma wins FDA nod for oral hydrocortisone solution - MSN
Eton Pharmaceuticals (ETON) Target Price Raised to $35 by HC Wai - GuruFocus
Eton Pharmaceuticals Inc (ETON) Shares Down 4.98% on May 29 - GuruFocus
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue - Benzinga
Sector Update: Health Care - marketscreener.com
Eton Pharmaceuticals stock rises on FDA approval of KHINDIVI By Investing.com - Investing.com Nigeria
Northern Trust Corp Purchases 22,827 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals stock rises on FDA approval of KHINDIVI - Investing.com Australia
Eton Pharma stock gains on FDA nod for Khindivi (ETON:NASDAQ) - Seeking Alpha
Eton Pharmaceuticals (ETON) Price Target Raised After FDA Approval | ETON Stock News - GuruFocus
Eton Pharmaceuticals Gains FDA Approval for KHINDIVI - TipRanks
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution - GlobeNewswire
Trading (ETON) With Integrated Risk Controls - news.stocktradersdaily.com
Jane Street Group LLC Has $857,000 Stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
individual investors who own 43% along with institutions invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) saw increase in their holdings value last week - Yahoo Finance
Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON) - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Shares Up 3.33% on May 19 - GuruFocus
Balyasny Asset Management L.P. Invests $158,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Q3 EPS Estimates for Eton Pharmaceuticals Cut by B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Earns “Buy” Rating from B. Riley - Defense World
Eton Pharmaceuticals Inc (ETON) Shares Down 3.4% on May 16 - GuruFocus
(ETON) Trading Report - news.stocktradersdaily.com
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $28.00 - Defense World
HC Wainwright Has Negative Outlook of ETON Q2 Earnings - Defense World
Eton Pharmaceuticals (ETON) Price Target Raised by B. Riley Secu - GuruFocus
Eton Pharmaceuticals (ETON) Price Target Raised by B. Riley Securities | ETON Stock News - GuruFocus
Eton Pharmaceuticals (ETON) Price Target Boosted Following Strong Q1 Results | ETON Stock News - GuruFocus
Results: Eton Pharmaceuticals, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts - simplywall.st
B. Riley Raises Price Target on Eton Pharmaceuticals to $26 From $24, Keeps Buy Rating - marketscreener.com
Eton Pharmaceuticals (NASDAQ:ETON) Trading Up 12% After Analyst Upgrade - Defense World
Eton outlines path to $100M near-term revenue with ET-400 launch and Increlex growth - MSN
Eton Pharmaceuticals’ Earnings Call: Growth and Prospects - TipRanks
Eton Pharmaceuticals (ETON) Price Target Raised by Craig-Hallum | ETON Stock News - GuruFocus
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2025 Earnings Call Transcript - Insider Monkey
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 12-Month High Following Analyst Upgrade - Defense World
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewswire
Eton Pharmaceuticals CEO to Lead Fireside Chat at Major Investor Conferences: How to Schedule 1-on-1 Meetings - Stock Titan
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates - MSN
A Glimpse Into The Expert Outlook On Eton Pharmaceuticals Through 4 Analysts - Benzinga
Eton Pharmaceuticals Secures Major Revenue Growth In Q1, Launches ET-400 In Sight - Nasdaq
Eton Pharmaceuticals (ETON) Surpasses Q1 Revenue Expectations wi - GuruFocus
Eton Pharmaceuticals: Buy Rating Backed by Successful Relaunches and Promising Growth Prospects - TipRanks
Raymond James Financial Inc. Takes $147,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
Eton Pharmaceuticals (ETON) Projects Strong Growth with New Acqu - GuruFocus
Eton Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Eton Pharmaceuticals Q1 2025 beats revenue estimates - Investing.com Nigeria
1.38%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):